ES2126616T3 - Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna. - Google Patents

Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna.

Info

Publication number
ES2126616T3
ES2126616T3 ES93111735T ES93111735T ES2126616T3 ES 2126616 T3 ES2126616 T3 ES 2126616T3 ES 93111735 T ES93111735 T ES 93111735T ES 93111735 T ES93111735 T ES 93111735T ES 2126616 T3 ES2126616 T3 ES 2126616T3
Authority
ES
Spain
Prior art keywords
vaccine
combined
component
increased immunogenicity
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93111735T
Other languages
English (en)
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2126616T3 publication Critical patent/ES2126616T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

SE PRESENTA UNA COMPOSICION DE VACUNA PEDIATRICA COMBINADA QUE SE CARACTERIZA, EN UNA DOSIS DE INMUNIZACION UNICA, UNA MEZCLA DE ANTIGENO DE PERTUSIS TETANOS Y DIFTERIA Y UN CONJUGADO DE FRAGMENTOS DEL ANTIGENO DE POLISACARIDO CAPSULAR DE HAEMOPHILUS INFLUENZAE DE TIPO B Y PROTEINA CRB-97 EN UN VEHICULO ACUOSO FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION DE VACUNA COMBINADA EXHIBE UNA RESPUESTA DE ANTICUERPOS REALZADA POR NIÑO A CADA UNO DE LOS 4 COMPONENTES DE VACUNA.
ES93111735T 1992-10-27 1993-07-22 Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna. Expired - Lifetime ES2126616T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (1)

Publication Number Publication Date
ES2126616T3 true ES2126616T3 (es) 1999-04-01

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93111735T Expired - Lifetime ES2126616T3 (es) 1992-10-27 1993-07-22 Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna.

Country Status (23)

Country Link
EP (1) EP0594950B1 (es)
JP (1) JPH07300427A (es)
KR (1) KR100289224B1 (es)
AT (1) ATE176157T1 (es)
AU (1) AU669570B2 (es)
CA (1) CA2109159A1 (es)
CZ (1) CZ283587B6 (es)
DE (2) DE69323264T4 (es)
DK (1) DK0594950T3 (es)
ES (1) ES2126616T3 (es)
FI (1) FI934725A (es)
GR (1) GR3029884T3 (es)
HK (1) HK1009931A1 (es)
HU (1) HU215149B (es)
IL (1) IL107387A (es)
LV (1) LV12271B (es)
NO (1) NO308588B1 (es)
NZ (1) NZ250029A (es)
PL (1) PL174130B1 (es)
RU (1) RU2121365C1 (es)
SG (1) SG47725A1 (es)
TW (1) TW256774B (es)
UA (1) UA27754C2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
DE69637597D1 (de) * 1995-06-07 2008-08-21 Glaxosmithkline Biolog Sa Vakzine mit einem Polysaccharide Antigen-Trägerprotein Konjugat und freiem Trägerprotein
BRPI9609414B8 (pt) 1995-06-23 2021-05-25 Smithkline Beecham Biologicals S A combinação de vacina e kit para produzir a mesma.
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
SK283565B6 (sk) * 1996-07-02 2003-09-11 Connaught Laboratories Limited Multivalentná imunogénna kompozícia a jej použitie
MXPA03000198A (es) * 2000-06-29 2004-09-13 Glaxosmithkline Biolog Sa Composicion de vacuna multivalente.
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR101130948B1 (ko) 2002-11-01 2012-03-30 글락소스미스클라인 바이오로지칼즈 에스.에이. 건조 공정
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
HUE031380T2 (en) 2005-06-27 2017-07-28 Glaxosmithkline Biologicals Sa A method for producing vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates

Also Published As

Publication number Publication date
IL107387A (en) 1997-04-15
NO308588B1 (no) 2000-10-02
LV12271B (en) 1999-07-20
DE69323264T2 (de) 1999-06-02
NZ250029A (en) 1994-09-27
UA27754C2 (uk) 2000-10-16
HUT67239A (en) 1995-03-28
EP0594950A1 (en) 1994-05-04
AU5029093A (en) 1994-05-12
NO933856L (no) 1994-04-28
PL174130B1 (pl) 1998-06-30
SG47725A1 (en) 1998-04-17
AU669570B2 (en) 1996-06-13
CZ283587B6 (cs) 1998-05-13
HU9303028D0 (en) 1994-01-28
DK0594950T3 (da) 1999-09-13
DE69323264T4 (de) 1999-10-14
KR940008698A (ko) 1994-05-16
FI934725A0 (fi) 1993-10-26
NO933856D0 (no) 1993-10-26
FI934725A (fi) 1994-04-28
TW256774B (es) 1995-09-11
DE69323264D1 (de) 1999-03-11
EP0594950B1 (en) 1999-01-27
KR100289224B1 (ko) 2001-05-02
CA2109159A1 (en) 1994-04-28
HK1009931A1 (en) 1999-06-11
CZ227293A3 (en) 1994-05-18
ATE176157T1 (de) 1999-02-15
JPH07300427A (ja) 1995-11-14
RU2121365C1 (ru) 1998-11-10
IL107387A0 (en) 1994-01-25
GR3029884T3 (en) 1999-07-30
HU215149B (hu) 2000-03-28
LV12271A (lv) 1999-05-20

Similar Documents

Publication Publication Date Title
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
IL115047A0 (en) Pneumococcal polysaccharide - recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections.
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
FI104046B1 (fi) Menetelmä konjugoidun oligosakkaridin valmistamiseksi
BR9507400A (pt) Composições imunogénicas de polissacaridio streptococal grupo a e processos
ES2126616T3 (es) Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna.
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
DE68915046T2 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
US6165468A (en) Antigenic carbohydrate linked to an immunogenic carrier
Isaacs Haemophilus influenzae type b immunization
Egorkov et al. Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 594950

Country of ref document: ES